Notably, the metastatic prostate cancer patients demonstrated a greater expression of all six genes assessed, including AR, androgen receptor variant 7 (AR-V7), PSA, PSMA, EpCAM and cytokeratin 19 (KRT-19) (Figure 9B). The gene discussed is AR; the disease is metastatic prostate carcinoma.